MBRS-50. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA

Group-3 medulloblastoma (MBL) is highly resistant to radiation (IR) and chemotherapy and has the worst prognosis. Hence, there is an urgent need to elucidate targets that sensitize these tumors to chemotherapy and IR. Employing standard assays for viability and sensitization to IR, we identified PRD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Sajesh, Babu, On, Ngoc, Omar, Refaat, Fediuk, Holly, Li, Lin, Alrushaid, Samaa, Wang, W, Pu, J, Sun, H D, Siahaan, Teruna, Werbowetski-Ogilvie, Tamra, Wolfl, Matthias, Remke, Marc, Ramaswamy, Vijay, Taylor, Michael, Eberehart, Charles, Symons, Marc, Ruggieri, Rosa Maria, Miller, Donald, Vanan, Issai
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012188/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados